亚丁酸是一种无毒的微分子,在体外和体外
Cara A Timpani1,2,3, Lorna Rasmussen4, Emma Rybalka1,2,3,5
1Institute for Health and Sport (IHeS), Victoria University, Melbourne, VIC 8001, Australia.
亚丁酸 (ASA) 在遗传性肌肉病变方面表现出极好的安全性. 这种小分子二碳酸盐在体外没有毒性,在小鼠中呈现急性全身毒性,LD50>5000mg/kg.
科学领域:
- 生物化学 生物化学
- 毒理学 毒理学 毒理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 腺酸 (ASA) 是一种潜在的治疗药物,用于与纯素代谢相关的遗传性肌肉病.
- 现有的数据表明慢性安全性,但缺乏药理动力学和毒理学概况.
研究的目的:
- 为了评估ASA在培养肌细胞上的体外毒性.
- 在小鼠模型中确定ASA的急性全身毒性.
主要方法:
- 在体外细胞培养试验中,使用神经母细胞进行了测定.
- 在小鼠中进行急性毒性测试,包括确定LD50.0.
- 主要器官的组织病理检查.主要器官的组织病理检查.
主要成果:
- ASA对培养的髓细胞没有表现出任何毒性.
- 在小鼠中,急性全身毒性显示LD50大于5000mg/kg.
- 在肝脏,脏和胃肠道中观察到轻微的死焦点,需要进一步调查.
结论:
- ASA是一种无毒的小分子,具有很高的安全率.
- 进一步的亚慢性和慢性口服暴露研究是有必要的,以充分评估遗传肌肉病的安全性.
更多相关视频
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
04:17Author Spotlight: Advancing Cellular and Protein Engineering to Control Biological Functions and Develop Novel Therapies
Published on: September 27, 2024
相关概念视频
Physical Properties of Amines
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Depolarizing Blockers: Pharmocokinetics
